Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 28 sie 2024 · It's now usually reserved for women at high risk of fracture who can't take other osteoporosis drugs. Women who are considering hormone replacement therapy to reduce menopausal symptoms, such as hot flashes, may factor in increased bone health when weighing the benefits and risks of estrogen treatment.

  2. 24 lut 2024 · For both men and women at increased risk of broken bones, the most widely prescribed osteoporosis medications are bisphosphonates. Examples include: Alendronate (Binosto, Fosamax). Risedronate (Actonel, Atelvia). Ibandronate. Zoledronic acid (Reclast, Zometa). Side effects include nausea, abdominal pain and heartburn-like symptoms.

  3. 13 paź 2017 · Denosumab may be considered a first-line treatment for women with osteoporosis who are at high risk of fracture or in women who can’t take bisphosphonates. Since denosumab isn’t metabolized by the kidneys, it’s also a first-line option for women with more advanced chronic kidney disease.

  4. 22 lip 2024 · Women with osteoporosis have many options for preserving bone strength and preventing fractures. The mainstays of treatment are bisphosphonate drugs.

  5. Teriparatide injection is used to treat osteoporosis in postmenopausal women who are at high risk for bone fracture. It reduces the risk of having bone and spine fracture in postmenopausal women with osteoporosis.

  6. Drugs used to treat osteoporosis can be classified into those that decrease bone resorption and those that increase bone formation. The differences in bone response between antiresorptive and formation-stimulating drugs and the point at which the antiresorptive drugs are most effective when bone turnover is increased are shown in Figure 1 .

  7. Estrogen replacement therapy is effective for the prevention and treatment of postmenopausal osteoporosis and should be offered to all women at high risk for osteoporosis.

  1. Ludzie szukają również